- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: April 2013
- Public Summary Document (PSD) April 2013 PBAC Meeting - PDF
Saxagliptin with metformin – April 2013
Saxagliptin with Metformin, tablet, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1000 mg, Kombiglyze®
Last updated
8 November 2023